Another accounting scandal, made in the UK.
A preliminary damages model.
The elephant in the room.
Swaps and interest rate hedges in commercial lending transactions.
Mispricing of US municipal bonds.
Still navigating in troubled waters?
Estimating pass-on damages.
An investigation of the Australian natural gas market.
Investigating manipulation of the main Canadian interest rate benchmark.
Fideres replicates ESMA’s study on closet indexers.
The role of pharmacy benefit managers In US drug pricing.
A pill of wisdom.
Trends in US antitrust litigation.
Could manufacturer drug cartels lead to higher generic drug prices?
The use of active share in identifying closet index funds.
London: +44 20 3397 5160
New York: +1 646 992 8510
Rome: +39 06 8587 0405
Frankfurt: +49 61 7491 63000
Johannesburg: +27 11 568 9611
Madrid: +34 919 494 330